Stockreport

Arcutis Announces Chief Financial Officer Transition

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on deve [Read more]